Novavax Is Worth 100% More Given Its Prospects and Value Metrics
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Novavax is worth roughly 100% more. NVAX stock is worth $419 given its high efficacy, cheap price, easy storage and cheap valuation compared to Moderna.
The post Novavax Is Worth 100% More Given Its Prospects and Value Metrics appeared first on InvestorPlace.
More From InvestorPlace